IP Library Granted Patent US 7,338,941
Granted Patent B2
US 7,338,941 · App. 10/426,241 · Granted Mar 4, 2008

Pharmaceutical compositions for lowering blood glucose and blood cholesterol levels

Assignee: Diakron Pharmaceuticals, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,338,941
App. No.
10/426,241
Granted
Mar 4, 2008
Kind
B2
Abstract

Methods of treating a mammal with high blood-glucose, or high blood-cholesterol, levels with isovitexin, and pharmaceutical compositions comprising the same are disclosed.

Claims (14)

1. A method of treating a mammal with a high blood glucose level comprising:

(a) identifying a mammal in need of said treatment; and

(b) administering to said mammal an effective amount of isolated isovitexin or a pharmaceutically acceptable salt, prodrug ester or prodrug amide thereof.

2. A method of treating a mammal with a high blood glucose level comprising:

(a) identifying a mammal in need of said treatment; and

(b) contacting the blood of said mammal with an effective amount of isolated isovitexin or a pharmaceutically acceptable salt, prodrug ester or prodrug amide thereof.

3. A method of treating a mammal with a high blood cholesterol level comprising:

(a) identifying a mammal in need of said treatment; and

(b) administering to said mammal an effective amount of isolated isovitexin or a pharmaceutically acceptable salt, prodrug ester or prodrug amide thereof.

4. A method of treating a mammal with a high blood cholesterol level comprising:

(a) identifying a mammal in need of said treatment; and

(b) contacting the blood of said mammal with an effective amount of isolated isovitexin or a pharmaceutically acceptable salt, prodrug ester, or prodrug amide thereof.

5. The method of any one of claims 1 - 4 , wherein said mammal is selected from the group consisting of mice, rats, rabbits, guinea pigs, dogs, cats, sheep, goats, cows, primates, monkeys, chimpanzees, apes, and humans.

6. The method of claim 5 , wherein said mammal is a human.

Assignments (6)
SECURITY INTEREST Recorded Dec 20, 2018
From: DIAKRON PHARMACEUTICALS, INC.
To: KNOBBE, MARTENS, OLSON & BEAR, LLP
Reel/Frame 048681/0011 →
SECURITY INTEREST TERMINATION Recorded Apr 21, 2015
From: KNOBBE, MARTENS, OLSON & BEAR, LLP
To: DIAKRON PHARMACEUTICALS, INC.
Reel/Frame 035475/0654 →
SECURITY INTEREST Recorded Oct 13, 2014
From: DIAKRON PHARMACEUTICALS, INC.
To: KNOBBE, MARTENS, OLSON & BEAR, LLP
Reel/Frame 033976/0001 →
RECORD TO CORRECT THE NAME OF THE 2ND ASSIGNOR ON AN ASSIGNMENT DOCUMENT PREVIOUSLY RECORDED ON REEL 014514 FRAME 0175. Recorded Jun 30, 2006
From: BIBBS, JEFFREY A.; RAO, SRIRAMA
To: DIAKRON PHARMACEUTICALS, INC.
Reel/Frame 018032/0508 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2006
From: BIBBS, JEFFREY A.; RAO, SRIRAMA
To: DIAKRON PHARMACEUTICALS, INC.
Reel/Frame 017915/0199 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2003
From: BIBBS, JEFFREY A.; RAO, SRIRAMO
To: DIAKROM PHARMACEUTICALS, INC.
Reel/Frame 014514/0175 →
Continuity (2)
Provisional Application 6037871600 · May 6, 2002
Related Publication 20040006128A1 · Jan 8, 2004